SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-026947
Filing Date
2023-09-27
Accepted
2023-09-27 17:12:37
Documents
17
Period of Report
2023-09-21
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20230927_8k.htm   iXBRL 8-K 26679
2 EXHIBIT 3.1 ex_573779.htm EX-3.1 2681
7 a1.jpg GRAPHIC 294503
8 a2.jpg GRAPHIC 239009
9 a3.jpg GRAPHIC 128589
  Complete submission text file 0001437749-23-026947.txt   1065678

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arch-20230921.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230921_def.xml EX-101.DEF 10733
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230921_lab.xml EX-101.LAB 14374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230921_pre.xml EX-101.PRE 10783
11 EXTRACTED XBRL INSTANCE DOCUMENT arch20230927_8k_htm.xml XML 2416
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 231285444
SIC: 3841 Surgical & Medical Instruments & Apparatus